- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Robert Pendleton Explains Preparing to Transition from Fee-for-Service
Many hospitals and healthcare systems don't fully understand their true cost of care, which will make the transition to an outcomes-based system difficult, said Robert Pendleton, MD, chief medical quality officer for University of Utah Healthcare.
Many hospitals and healthcare systems don’t fully understand their true cost of care, which will make the transition from fee-for-service difficult, said Robert Pendleton, MD, chief medical quality officer for University of Utah Healthcare in Salt Lake City.
“In healthcare we have been unfortunately lagging in terms of developing really meaningful metrics,” Dr Pendleton said.
He added that University of Utah Healthcare spent time to understand its true cost of care to understand where its inefficiencies were.
Impact of Amivantamab-Lazertinib on EGFR, MET Resistance Alterations in NSCLC: Danny Nguyen, MD
September 15th 2025The combination of amivantamab and lazertinib in first-line non–small cell lung cancer (NSCLC) significantly reduces resistance mechanisms with implications for second-line treatment, said Danny Nguyen, MD, of City of Hope.
Read More
Disparities in Biomarker Testing Impact Nonsquamous NSCLC Outcomes: Surbhi Singhal, MD
September 6th 2025Surbhi Singhal, MD, of the University of California Davis, discussed disparities in biomarker testing among patients diagnosed with stage IV nonsquamous non–small cell lung cancer (NSCLC).
Read More
